All Stories

  1. Response to `letter to the editor: ‘Strategies to enhance access to diagnosis and treatment for Chagas disease patients in Latin America’´
  2. Strategies to enhance access to diagnosis and treatment for Chagas disease patients in Latin America
  3. Molecular diagnostics for Chagas disease: up to date and novel methodologies
  4. Documento de consenso sobre el abordaje de la enfermedad de Chagas en atención primaria de salud de áreas no endémicas
  5. Chagas disease: from Latin America to the world
  6. Prevalence of Chagas Disease in Latin-American Migrants Living in Europe: A Systematic Review and Meta-analysis
  7. Parasitosis importadas en la población inmigrante en España
  8. Arthritis and Benznidazole: More Closely Related than We Thought
  9. Health Policies to Control Chagas Disease Transmission in European Countries
  10. Economic crisis and increased immigrant mobility: new challenges in managing Chagas disease in Europe
  11. Characterization of Digestive Involvement in Patients with Chronic T. cruzi Infection in Barcelona, Spain
  12. Chagas pediátrico en zona no endémica
  13. Biological markers for evaluating therapeutic efficacy in Chagas disease, a systematic review
  14. The need for global collaboration to tackle hidden public health crisis of Chagas disease
  15. Evaluation of a chemiluminescent enzyme-linked immunosorbent assay for the diagnosis of Trypanosoma cruzi infection in a nonendemic setting
  16. Socio-Cultural Aspects of Chagas Disease: A Systematic Review of Qualitative Research
  17. Evaluation of a chemiluminescent enzyme-linked immunosorbent assay for the diagnosis of Trypanosoma cruzi infection in a nonendemic setting
  18. Neurological complications of dengue virus infection
  19. Evaluating Chagas disease progression and cure through blood-derived biomarkers: a systematic review
  20. Cytokine Profiling in Immigrants with Clinical Malaria after Extended Periods of Interrupted Exposure to Plasmodium falciparum
  21. High Antibody Responses against Plasmodium falciparum in Immigrants after Extended Periods of Interrupted Exposure to Malaria
  22. Pulmonary Infiltrates and Eosinophilia in a 25-Year-Old Traveler
  23. Myocardial involvement in Chagas disease: Insights from cardiac magnetic resonance
  24. Refractory giardiasis in Spanish travellers
  25. Cytokine and Antibody Responses to Plasmodium falciparum in Naïve Individuals during a First Malaria Episode: Effect of Age and Malaria Exposure
  26. Immunosuppression and Chagas Disease: A Management Challenge
  27. Potential use of synthetic α-galactosyl-containing glycotopes of the parasite Trypanosoma cruzi as diagnostic antigens for Chagas disease
  28. Trypanosoma cruzi paraflagellar rod proteins 2 and 3 contain immunodominant CD8+ T-cell epitopes that are recognized by cytotoxic T cells from Chagas disease patients
  29. Fitness and Molecular Mechanisms of Resistance to Rifaximin in In Vitro Selected Escherichia coli Mutants
  30. Viscerotropic disease: Case definition and guidelines for collection, analysis, and presentation of immunization safety data
  31. Myocardial Deformation Analysis in Chagas Heart Disease With the Use of Speckle Tracking Echocardiography
  32. Bolivian migrants with Chagas disease in Barcelona, Spain: a qualitative study of dietary changes and digestive problems
  33. Guidelines on the Treatment of Chronic Coinfection byTrypanosoma cruziand HIV Outside Endemic Areas
  34. Identification of HLA-A∗02:01-restricted CTL epitopes in Trypanosoma cruzi heat shock protein-70 recognized by Chagas disease patients
  35. CTX-M-15–producing Enteroaggregative Escherichia coli as Cause of Travelers’ Diarrhea
  36. CTX-M-15–producing Enteroaggregative Escherichia coli as Cause of Travelers' Diarrhea
  37. Función endotelial y concentración de proteína C reactiva de alta sensibilidad en pacientes con enfermedad de Chagas que viven en áreas no endémicas
  38. Endothelial Function and High-Sensitivity C-reactive Protein Levels in Patients With Chagas Disease Living in a Nonendemic Area
  39. Short-term follow-up of chagasic patients after benznidazole treatment using multiple serological markers
  40. Rapid Suppression of HIV-RNA Is Associated with Improved Control of Immune Activation in Mozambican Adults Initiating Antiretroviral Therapy with Low CD4 Counts
  41. Recommendations for management of Chagas disease in organ and hematopoietic tissue transplantation programs in nonendemic areas
  42. Malaria chemoprophylaxis recommendations for immigrants to Europe, visiting relatives and friends - a Delphi method study
  43. Molecular Surveillance of Circulating Dengue Genotypes Through European Travelers
  44. Economic evaluation of Chagas disease screening of pregnant Latin American women and of their infants in a non endemic area
  45. Chagas Disease among the Latin American Adult Population Attending in a Primary Care Center in Barcelona, Spain
  46. Incidence and Predictors of Immune Reconstitution Inflammatory Syndrome in a Rural Area of Mozambique
  47. A high-performance liquid chromatographic method for benznidazole quantitation in plasma of patients with Chagas disease
  48. Epidemiology of imported malaria among children and young adults in Barcelona (1990-2008)
  49. Co-infection with two emergent old pathogens: Trypanosoma cruzi and Helicobacter pylori
  50. The incidence of malaria in travellers to South-East Asia: is local malaria transmission a useful risk indicator?
  51. Chagas Cardiomiopathy: The Potential of Diastolic Dysfunction and Brain Natriuretic Peptide in the Early Identification of Cardiac Damage
  52. Clinical and epidemiological features of 33 imported Strongyloides stercoralis infections
  53. Congenital transmission of Chagas disease: a clinical approach
  54. Chagas disease in Spain, the United States and other non-endemic countries
  55. Chagas disease and stroke
  56. Utilidad de un test inmunocromatográfico para el cribado de la enfermedad de Chagas en asistencia primaria
  57. Diagnosis, management and treatment of chronic Chagas’ gastrointestinal disease in areas where Trypanosoma cruzi infection is not endemic
  58. Prevalence of Chagas disease in the Latin American immigrant population in a primary health centre in Barcelona (Spain)
  59. Characterization of the enzyme aac(3)-id in a clinical isolate of Salmonella enterica serovar Haifa causing traveler's diarrhea
  60. Molecular and serologic markers of acute dengue infection in naive and flavivirus-vaccinated travelers
  61. Vaccination Strategies Against Hepatitis A in Travelers Older Than 40 Years: An Economic Evaluation
  62. Clinical profile of Trypanosoma cruzi infection in a non-endemic setting: Immigration and Chagas disease in Barcelona (Spain)
  63. Prevalence and Vertical Transmission of Trypanosoma cruzi Infection among Pregnant Latin American Women Attending 2 Maternity Clinics in Barcelona, Spain
  64. Imported malaria among African immigrants: is there still a relationship between developed countries and their ex-colonies?
  65. Increased expression levels of the pvcrt-o and pvmdr1 genes in a patient with severe Plasmodium vivax malaria
  66. Control de la transmisión vertical de Trypanosoma cruzi en España: principal reto de la patología importada
  67. Seroprevalence ofTrypanosoma cruziinfection in at-risk blood donors in Catalonia (Spain)
  68. Variability in Malaria Prophylaxis Prescribing Across Europe: A Delphi Method Analysis
  69. Imported Dengue Hemorrhagic Fever, Europe
  70. Estudio clinicoepidemiológico del dengue importado en España
  71. Epidemiologia del VIH/sida en el mundo y el fenómeno migratorio actual
  72. Yellow Fever–Associated Viscerotropic Disease in Barcelona, Spain
  73. Presentación clínica y complicaciones de malaria importada por Plasmodium falciparum en dos grupos de población: viajeros e inmigrantes
  74. Imported malaria in a cosmopolitan European city: A mirror image of the world epidemiological situation
  75. Measles in Travelers: Are We Aware Enough?
  76. Diagnóstico, manejo y tratamiento de la cardiopatía chagásica crónica en áreas donde la infección por Trypanosoma cruzi no es endémica
  77. In vitro antimicrobial activity of rifaximin against enteropathogens causing traveler's diarrhea
  78. Epidemiology and Clinical Presentation of Shigellosis in Children Less Than Five Years of Age in Rural Mozambique
  79. Congenital Trypanosoma cruzi infection in a non-endemic area
  80. Imported Acute Histoplasmosis With Rheumatologic Manifestations in Spanish Travelers: Table 1
  81. Development of a real-time PCR assay for Trypanosoma cruzi detection in blood samples
  82. Salmonella ovarian abscess following travel diarrhoea episode
  83. Severe Dengue Virus Infection in Travelers: Risk Factors and Laboratory Indicators
  84. Trends in antimicrobial resistance in Campylobacter spp. causing traveler's diarrhea
  85. Diagnóstico, manejo y tratamiento de la cardiopatía chagásica crónica en áreas donde la infección por Trypanosoma cruzi no es endémica
  86. Diagnosis, Management, and Treatment of Chronic Chagas' Heart Disease in Areas Where Trypanosoma cruzi Infection Is Not Endemic
  87. ¿Cuánta primaquina es necesaria para erradicar los hipnozoitos de Plasmodium vivax?
  88. Vigilancia epidemiológica mediante marcadores moleculares de resistencia frente a antimaláricos en aislados de Plasmodium falciparum importados a Barcelona, España
  89. Validación de la técnica de PCR para la detección de Escherichia coli enteroagregativa causante de diarrea del viajero
  90. Diagnóstico y tratamiento de la Enfermedad de Chagas importada
  91. Paludismo importado de Senegal: a propósito de 17 casos en el año 2000
  92. Screening for Mutations Related to Atovaquone/Proguanil Resistance in Treatment Failures and Other Imported Isolates of Plasmodium falciparum in Europe
  93. Enfermedades infecciosas e inmigración
  94. Aetiology, epidemiology, and management of traveller's diarrhoea
  95. Intoxicación por ciguatoxina en viajeros
  96. Enfermedades infecciosas e inmigración
  97. Intoxicación por ciguatoxina en viajeros
  98. Reply
  99. Neurocisticercosis: ¿una enfermedad importada?
  100. Ciclosporiasis: estudio clinicoepidemiológico en viajeros con Cyclospora cayetanensis importada
  101. Fiebre de Katayama en turistas españoles: análisis de 25 casos
  102. Riesgo del comportamiento sexual de los viajeros españoles al extranjero
  103. Profilaxis de la diarrea del viajero
  104. Enteroaggregative Escherichia coli Virulence Factors in Traveler's Diarrhea Strains
  105. Campylobacter jejuni as a Cause of Traveler's Diarrhea: Clinical Features and Antimicrobial Susceptibility
  106. Antimicrobial Resistance of Nontyphoidal Salmonella Isolates in Traveler's Diarrhea
  107. Cyclospora in Patients with Traveller's Diarrhea
  108. Cyanobacteria-like Body (CLB) in Travellers with Diarrhea
  109. Sero-epidemiologia de la toxoplasmosis en dos comunidades de Rwanda (Africa Central)
  110. Utilidad de las muestras de sangre total desecada en papel de filtro en la detección de anticuerpos antitoxoplasma
  111. MALARIA CHEMOPROPHYLAXIS AND TRAVELLER'S WEIGHT
  112. Epidemiology of malaria in Nyarutovu (Rwanda): a clinical, parasitological and serological study